Sartorius (0NIR – Research Report) received a Hold rating and a €240.00 price target from Kepler Capital analyst Oliver Reinberg on April 23.

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

Sartorius (0NIQ) (($DE:SRT)) has held its Q1 earnings call. Read on for the main highlights of the call. The recent earnings call for Sartorius ...

Growth is driven by heightened demand for water and wastewater treatment due to water scarcity and stringent environmental ...

Shares of Sartorius (OTCPK:SARTF) spiked in European trading on Wednesday after the German life sciences company recorded a ...

German medical lab equipment maker Sartorius saw a jump in first-quarter net profit to €48.5 million ($55.2 million), up from ...

EQS-News: SARTORIUS AG / Key word (s): Quarter Results/Forecast Strong start to the year: Sartorius achieves significant profitable growth in the first quarter (news with additional features) 16.04 ...

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...

Our partnership with BICO has evolved since 2022, where our most recent collaboration in lab automation, combining Sartorius' Octet ® BLI Automation and Integration and Biosero's software ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...